Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei

David P. AuCoin, Dana E. Reed, Nicole L. Marlenee, Richard A. Bowen, Peter Thorkildson, Barbara M. Judy, Alfredo Torres, Thomas R. Kozel

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.

Original languageEnglish (US)
Article numbere35386
JournalPLoS One
Volume7
Issue number4
DOIs
StatePublished - Apr 17 2012

Fingerprint

Burkholderia pseudomallei
Polysaccharides
monoclonal antibodies
polysaccharides
lipopolysaccharides
Monoclonal Antibodies
Lipopolysaccharides
Melioidosis
antigens
Immunization
Antigens
Passive Immunization
Bacilli
Surface Antigens
Bacillus
Bacteria
immunization
spleen
urine
Stem Cells

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

AuCoin, D. P., Reed, D. E., Marlenee, N. L., Bowen, R. A., Thorkildson, P., Judy, B. M., ... Kozel, T. R. (2012). Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei. PLoS One, 7(4), [e35386]. https://doi.org/10.1371/journal.pone.0035386

Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei. / AuCoin, David P.; Reed, Dana E.; Marlenee, Nicole L.; Bowen, Richard A.; Thorkildson, Peter; Judy, Barbara M.; Torres, Alfredo; Kozel, Thomas R.

In: PLoS One, Vol. 7, No. 4, e35386, 17.04.2012.

Research output: Contribution to journalArticle

AuCoin, David P. ; Reed, Dana E. ; Marlenee, Nicole L. ; Bowen, Richard A. ; Thorkildson, Peter ; Judy, Barbara M. ; Torres, Alfredo ; Kozel, Thomas R. / Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei. In: PLoS One. 2012 ; Vol. 7, No. 4.
@article{fe11ce72e18b4951a3aad19dbcaae434,
title = "Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei",
abstract = "Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.",
author = "AuCoin, {David P.} and Reed, {Dana E.} and Marlenee, {Nicole L.} and Bowen, {Richard A.} and Peter Thorkildson and Judy, {Barbara M.} and Alfredo Torres and Kozel, {Thomas R.}",
year = "2012",
month = "4",
day = "17",
doi = "10.1371/journal.pone.0035386",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei

AU - AuCoin, David P.

AU - Reed, Dana E.

AU - Marlenee, Nicole L.

AU - Bowen, Richard A.

AU - Thorkildson, Peter

AU - Judy, Barbara M.

AU - Torres, Alfredo

AU - Kozel, Thomas R.

PY - 2012/4/17

Y1 - 2012/4/17

N2 - Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.

AB - Burkholderia pseudomallei is a Gram-negative bacillus that is the causative agent of melioidosis. The bacterium is inherently resistant to many antibiotics and mortality rates remain high in endemic areas. The lipopolysaccharide (LPS) and capsular polysaccharide (CPS) are two surface-associated antigens that contribute to pathogenesis. We previously developed two monoclonal antibodies (mAbs) specific to the CPS and LPS; the CPS mAb was shown to identify antigen in serum and urine from melioidosis patients. The goal of this study was to determine if passive immunization with CPS and LPS mAbs alone and in combination would protect mice from a lethal challenge with B. pseudomallei. Intranasal (i.n.) challenge experiments were performed with B. pseudomallei strains 1026b and K96423. Both mAbs provided significant protection when administered alone. A combination of mAbs was protective when low doses were administered. In addition, combination therapy provided a significant reduction in spleen colony forming units (cfu) compared to results when either the CPS or LPS mAbs were administered alone.

UR - http://www.scopus.com/inward/record.url?scp=84859820563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859820563&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0035386

DO - 10.1371/journal.pone.0035386

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e35386

ER -